About the Company
We do not have any company description for IMMUCELL CORP /DE/ at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ICCC News
ImmuCell Corporation: ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024
ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically ...
ImmuCell Corp ICCC
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Immucell Corp.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024
PORTLAND, Maine, April 09, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and ...
Immucell Corp.
Invest with your heart and your phone with as little as $1 with these ESG and socially responsible investing apps.
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024
Brigham, President and CEO of ImmuCell. “This high mark in sales exceeds our next best quarter of $6 million during the first quarter of 2022 by 21%, or $1.3 million.” As the ...
Loading the latest forecasts...